Key facts
- Asterix Foods’s last known valuation is $5.5M (May 2022).
- It has raised $4.2M; the latest was Early Stage VC ($4.2M) in Oct 2025.
- Notable investors include SOSV, IndieBio, Innovation Authority, CPT Capital, Grok Ventures — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Asterix Foods
- ·The full record, as it builds
Funding rounds
No funding rounds for Asterix Foods are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Asterix Foods
Operator of a biotechnology platform intended to build protein production using plant cells. The company's platform is developing and growing bioactive proteins for food that are scalable, functional and complex, enabling users with plant cell-cultured and animal-free proteins.
- Sector
- Business Products and Services (B2B)
- HQ
- Tel Aviv, Israel
- Founded
- 2022
- Employees
- 6
- Website
- asterixfoods.com/
- Ownership
- Privately Held (backing)
Asterix Foods doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Asterix Foods shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Asterix Foods in its N-PORT filings yet. We sweep new filings monthly.